A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVSQIV in Healthy Adults

A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Aged 18 Years and Above.

NCT02214225 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of Two Doses of DCVC H1 HA mRNA-LNP in Healthy Adults

NCT05945485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Intramuscular CodaVax-H1N1 in Healthy Adults

NCT05223179 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05823974 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity and Safety of Pandemic Influenza Vaccines in Adults Aged 18 - 49 Years Old

NCT01236040 ·Status: COMPLETED ·Phase: PHASE1

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5407 in Adult Participants18 Years of Age and Older

NCT05553301 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5413 in Adult Participants18 Years of Age and Older

NCT05650554 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Find and Confirm the Dose and Assess Safety, Reactogenicity and Immune Response of a Vaccine Against Pandemic H5N1 Influenza Virus in Healthy Younger and Older Adults

NCT06382311 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety Study of Quadrivalent Subunit Influenza Vaccine in People Aged 3 Years and Older

NCT07332689 ·Status: COMPLETED

A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults

NCT05446740 ·Status: COMPLETED ·Phase: PHASE1

A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults

NCT05333289 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Immunogenicity, Safety and Tolerability of a Plant-Derived Seasonal Virus-Like-Particle Quadrivalent Influenza Vaccine in Adults

NCT02233816 ·Status: COMPLETED ·Phase: PHASE2

A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

NCT04956575 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study About Modified RNA Vaccines Against Influenza in Healthy Adults

NCT06436703 ·Status: COMPLETED ·Phase: PHASE2

Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older

NCT01992094 ·Status: COMPLETED ·Phase: PHASE3

Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml)

NCT03853993 ·Status: COMPLETED ·Phase: PHASE3

A Study of mRNA-1011.1, mRNA-1011.2, and mRNA-1012.1 Candidate Seasonal Influenza Vaccines in Healthy Adults

NCT05827068 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Single-ascending-dose Study of the Safety and Immunogenicity of NasoVAX

NCT03232567 ·Status: COMPLETED ·Phase: PHASE2

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older

NCT06015282 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

NCT01201902 ·Status: COMPLETED ·Phase: PHASE3

Safety, Tolerability, and Immunogenicity of GC3106 (Quadrivalent Cell-culture Based Influenza Vaccine)

NCT02249221 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of Fluzone® Quadrivalent, Fluzone® Intradermal Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines in Adults

NCT02563093 ·Status: COMPLETED ·Phase: PHASE4

Safety & Immunogenicity of an Alternative Immunization Schedule of GSK Bio's Pandemic Influenza Vaccine (GSK1119711A)

NCT00430521 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine Influsplit™ Tetra (Fluarix™ Tetra) (GSK2321138A) When Co-administered With Pneumovax™ 23 in Adults 50 Years of Age and Older

NCT02218697 ·Status: COMPLETED ·Phase: PHASE3

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

NCT05624606 ·Status: COMPLETED ·Phase: PHASE1/PHASE2